Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Mitogenic effect of HIV-infected human T cell lines on mouse B cells mediated by surface immunoglobulin.

Arase N, Arase H, Ohki K, Nishino Y, Ikuta K, Onoe K.

Clin Exp Immunol. 1996 Jan;103(1):24-9.

2.

Productive infection of normal CD40-activated human B lymphocytes by HIV-1.

Poulin L, Paquette N, Moir S, Lapointe R, Darveau A.

AIDS. 1994 Nov;8(11):1539-44.

PMID:
7531456
4.

Resistance to apoptosis in HIV-infected CD4+ T lymphocytes is mediated by macrophages: role for Nef and immune activation in viral persistence.

Mahlknecht U, Deng C, Lu MC, Greenough TC, Sullivan JL, O'Brien WA, Herbein G.

J Immunol. 2000 Dec 1;165(11):6437-46.

5.

Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures.

Döpper S, Wilflingseder D, Prodinger WM, Stiegler G, Speth C, Dierich MP, Stoiber H.

Eur J Immunol. 2003 Aug;33(8):2098-107.

6.

Interaction of B cells with activated T cells reduces the threshold for CD40-mediated B cell activation.

Klaus GG, Holman M, Johnson-Léger C, Christenson JR, Kehry MR.

Int Immunol. 1999 Jan;11(1):71-9.

PMID:
10050675
7.

Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function.

Malaspina A, Moir S, Kottilil S, Hallahan CW, Ehler LA, Liu S, Planta MA, Chun TW, Fauci AS.

J Immunol. 2003 Jun 15;170(12):5965-72.

8.

Effects of prostratin on T-cell activation and human immunodeficiency virus latency.

Korin YD, Brooks DG, Brown S, Korotzer A, Zack JA.

J Virol. 2002 Aug;76(16):8118-23.

9.
10.

Production of HIV-1 by human B cells infected in vitro: characterization of an EBV genome-negative B cell line chronically synthetizing a low level of HIV-1 after infection.

Fritsch L, Marechal V, Schneider V, Barthet C, Rozenbaum W, Moisan-Coppey M, Coppey J, Nicolas JC.

Virology. 1998 May 10;244(2):542-51.

11.

Establishment of MAIDS-defective virus-infected B cell lines and their characterization.

Klein SJ, Simard C, Jolicoeur P.

Virology. 1998 May 10;244(2):283-93.

12.

In vivo CD40-CD154 (CD40 ligand) interaction induces integrated HIV expression by APC in an HIV-1-transgenic mouse model.

Chougnet C, Freitag C, Schito M, Thomas EK, Sher A, Shearer GM.

J Immunol. 2001 Mar 1;166(5):3210-7.

13.

Monocyte accessory cell function in patients infected with the human immunodeficiency virus.

Twigg HL 3rd, Weissler JC, Yoffe B, Ball EJ, Lipscomb MF.

Clin Immunol Immunopathol. 1991 Jun;59(3):436-48.

PMID:
1827620
14.

Membrane tumor necrosis factor-alpha (TNF-alpha) expressed on HTLV-I-infected T cells mediates a costimulatory signal for B cell activation--characterization of membrane TNF-alpha.

Higuchi M, Nagasawa K, Horiuchi T, Oike M, Ito Y, Yasukawa M, Niho Y.

Clin Immunol Immunopathol. 1997 Feb;82(2):133-40.

PMID:
9000481
15.

HIV-1 Nef binding protein expressed on the surface of murine blood cells.

Okada H, Morikawa S, Tashiro M.

Med Microbiol Immunol. 1998 Mar;186(4):201-7.

PMID:
9574903
16.

Pertussis toxin B-oligomer dissociates T cell activation and HIV replication in CD4 T cells released from infected lymphoid tissue.

Alfano M, Grivel JC, Ghezzi S, Corti D, Trimarchi M, Poli G, Margolis L.

AIDS. 2005 Jul 1;19(10):1007-14.

PMID:
15958831
17.

B cell-mediated infection of stimulated and unstimulated autologous T lymphocytes with HIV-1: role of complement.

Doepper S, Stoiber H, Kacani L, Sprinzl G, Steindl F, Prodinger WM, Dierich MP.

Immunobiology. 2000 Sep;202(3):293-305.

PMID:
11045664
19.

HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.

Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI.

Cytometry B Clin Cytom. 2007 Jan 15;72(1):14-21.

20.

Both T and B cells shed infectious mouse mammary tumor virus.

Dzuris JL, Golovkina TV, Ross SR.

J Virol. 1997 Aug;71(8):6044-8.

Supplemental Content

Support Center